Hormone therapy may increase ovarian cancer risk

by Poonam Singhal



Compared with women who have never taken hormone therapy, those who currently take it or who have taken it in the past are at increased risk of ovarian cancer.

The new study is published in the July 15 issue of Journal of the American Medical Association - JAMA.

Primary prevention of ovarian cancer is challenging because little is known about its cause. Studies have suggested an increased risk of ovarian cancer among women taking postmenopausal hormone therapy (HT).

Lina Steinrud Mørch, M.Sc., of Rigshospitalet, Copenhagen University, Denmark, and colleagues conducted a study to examine the risk of ovarian cancer associated with hormone therapy use. The study included all Danish women age 50 through 79 years from 1995 through 2005 through linkage to Danish national registers.

Prescription data from the National Register of Medicinal Product Statistics provided individually updated information on HT use. The National Cancer Register and Pathology Register provided ovarian cancer incidence data. The analysis included a total of 909,946 women without hormone-sensitive cancer or who had not had both ovaries removed.

At the end of follow-up, 63 percent of the women had not been taking HT, 22 percent were previous users of hormones, and 9 percent current users of hormones. Among the current users, 46 percent had used hormones for more than 7 years.

During an average of 8 years of follow-up, 3,068 ovarian cancers were detected. Compared with never users, current users of HT had an overall 38 percent increased risk of ovarian cancer.

The risk of ovarian cancer declined with longer time since last HT use. The risk of ovarian cancer did not differ significantly by formulation, regimen, type of progestin or route of administration.

The absolute risk indicated approximately 1 extra ovarian cancer for roughly 8,300 women taking hormone therapy each year. "If this association is causal, use of hormones has resulted in roughly 140 extra cases of ovarian cancer in Denmark over the mean follow-up of 8 years, i.e., 5 percent of the ovarian cancers in this study. Even though this share seems low, ovarian cancer remains highly fatal, so accordingly this risk warrants consideration when deciding whether to use HT," the authors write.


(Poonam Singhal -- sub-editor compiled and published Hormone therapy may increase ovarian cancer risk at HealthNewsTrack on July 15, 2009 sourced from Journal of the American Medical Association - http://jama.ama-assn.org/)

Ovarian Cancer - recent articles and current news stories:

- Ovarian cancer screening does not improve survival
- Preventive surgeries better in breast or ovarian cancer patients
- Initial trials on new ovarian cancer tests exhibit extremely high accuracy
- Simple blood test may detect ovarian cancer early
- Symptoms have little value to diagnose ovarian cancer earlier

Ovarian Cancer article/news source:

Read more health articles from Journal of the American Medical Association and health articles from USA.

Ovarian Cancer - search related terms:

Cancer, Hormone, Hormone therapy, Ovarian cancer, Ovary, Pathology, Postmenopausal hormone therapy, Progestin,
Ovarian Cancer books,

Searched keywords: ovarian cancer symptoms (8),

Subscribe to Health News by Email

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
2.31